Table 4.
Pre- and posttreatment liver indices
| Pre | Post | |
|---|---|---|
| Child-Pugh | ||
| A (5-6) | 26 (70%) | 19 (54%) |
| B (7-9) | 11 (30%) | 14 (40%) |
| C (10-15) | 0 (0%) | 2 (6%) |
| Child-Pugh increase (any) | ||
| Present | 13 (35%) | |
| Absent | 24 (65%) | |
| Child-Pugh increase by 2 with 3 months | ||
| Present | 6 (16%) | |
| Absent | 31 (84%) | |
| ALBI score | ||
| Median (Q1-Q3) | -2.42 (-2.76 to -2.08) | -2.02 (-2.59 to -1.72) |
| ALBI grade | ||
| 1 | 14 (38%) | 9 (26%) |
| 2 | 23 (62%) | 22 (63%) |
| 3 | 0 (0%) | 4 (11%) |
| Not reported | 0 (0%) | 2 (NA) |
| MELD score | ||
| Median (Q1-Q3) | 9 (7-11) | 10 (8-15) |
| MELD | ||
| <10 | 22 (60%) | 19 (51%) |
| 10-20 | 14 (38%) | 13 (35%) |
| >20 | 1 (3%) | 5 (14%) |
Abbreviations: ALBI = albumin bilirubin; MELD = model for end-stage liver disease.